retatrutide delivery A New Obesity Drug Delivered Surgery-Level Weight Loss in Clinical Trials Retatrutide: Benefits, Mechanism & Research

Researchers had not previously examined whether GLP-1 medications might reduce the risk of substance use disorders more broadly or whether they could also lower the risk of serious outcomes such as overdose and drug-related death

Just two weeks later, on 1 April 2026, the FDA approved Foundayo, Eli Lillys brand name for orforglipron, making it the first small-molecule, non-peptide oral GLP-1 receptor agonist approved for chronic weight management

Jorge Moreno, MD, is an internal medicine physician and obesity medicine specialist at Yale Medicine

and when undergoing imaging studies that require fasting preparation

Eat more fiber : Gradually increase fiber through fruits, vegetables, whole grains or a fiber supplement if necessary

Congress gave the agency the authority under the Public Health Service Act to regulate biological products, which includes proteins and products analogous to proteins that are applicable ...